CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 24.80 +1.80 (+7.83%) As of 06/13/2025 11:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 148.00%. In the past month, the stock has increased 18.66%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 24.80 with a market cap of £2.70 million and volume of 199,921 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+23.38%1 Month Performance+18.66%3 Month Performance+302.53%Year-To-Date Performance+148.00% CRTX Stock Chart for Sunday, June, 15, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025GBX 21.73GBX 24.80+14.13%GBX 24.90GBX 22199,921 shs£2.70 million06/12/2025GBX 21.66GBX 21.73+0.32%GBX 24GBX 2161,714 shs£2.37 million06/11/2025GBX 20.10GBX 21.66+7.76%GBX 23.85GBX 19184,339 shs£2.36 million06/10/2025GBX 19GBX 20.10+5.79%GBX 22GBX 1922,434 shs£2.19 million06/09/2025GBX 18GBX 19+5.56%GBX 22GBX 1829,988 shs£2.07 million06/06/2025GBX 17GBX 18+5.88%GBX 21GBX 1853,321 shs£1.96 million06/05/2025GBX 18.21GBX 17-6.65%GBX 19GBX 173,263 shs£1.85 million06/04/2025GBX 18.10GBX 18.21+0.62%GBX 21GBX 18.2124,597 shs£1.98 million06/03/2025GBX 17GBX 18.10+6.47%GBX 18.10GBX 173,143 shs£1.97 million06/02/2025GBX 17GBX 17GBX 19.97GBX 1732,678 shs£1.85 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025GBX 17.36GBX 17-2.07%GBX 18.50GBX 1725 shs£1.85 million05/29/2025GBX 17GBX 17.36+2.12%GBX 17.36GBX 175,649 shs£1.89 million05/28/2025GBX 17GBX 17GBX 18.50GBX 171,006 shs£1.85 million05/27/2025GBX 17GBX 17GBX 17.36GBX 172,203 shs£1.85 million05/26/2025GBX 17GBX 17GBX 18.50GBX 171,050 shs£1.85 million05/23/2025GBX 20GBX 17-15.00%GBX 18.50GBX 171,050 shs£1.85 million05/22/2025GBX 17GBX 20+17.65%GBX 20GBX 17.36720 shs£2.18 million05/21/2025GBX 17GBX 17GBX 18.50GBX 1710,922 shs£1.85 million05/20/2025GBX 19GBX 17-10.53%GBX 20GBX 1792,987 shs£1.85 million05/19/2025GBX 18GBX 19+5.56%GBX 19GBX 1799,080 shs£2.07 million05/16/2025GBX 20.90GBX 18-13.88%GBX 19.90GBX 1875,724 shs£1.96 million05/15/2025GBX 21.20GBX 20.90-1.42%GBX 24GBX 1926,570 shs£2.28 million05/14/2025GBX 21.10GBX 21.20+0.47%GBX 24.55GBX 21130,799 shs£2.31 million Related Companies Galileo Resources Stock Price Chart Phoenix Copper Stock Price Chart Blencowe Resources Stock Price Chart Tirupati Graphite Stock Price Chart Celsius Resources Stock Price Chart Vast Resources Stock Price Chart Strategic Minerals Stock Price Chart Premier African Minerals Stock Price Chart Firering Strategic Minerals Stock Price Chart GreenRoc Mining Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRTX Stock Free CRTX Stock Alerts